Logo

Health Discovery Raises $3M Through Stock Offering

Mar 23, 2005

NEW YORK, March 23 (GenomeWeb News) - Health Discovery, a Savannah, Ga.-based pharmacogenomics company, has raised $3 million through a stock offering, according to a report by a local Savannah business publication.

 

The Business Reporter today reported that Health Discovery's stock offering closed $10,000 short of $3 million, and that the firm would be pumping the revenue into its development of biomarkers and pathways.


Health Discovery CEO and Chairman Stephen Barnhill told The Business Reporter that the 2-year-old firm would be adding 10 workers to the company's staff over the following year. Health Discovery currently employs 15 people at offices in Georgia, Texas, and California, and has registered nearly 80 patents according to The Business Reporter.

The company announced partnerships with Stanford University and the MD Anderson Cancer Center last year.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.